45 results
6-K
EX-99.1
CANF
Can-Fite Biopharma Ltd
28 Feb 24
Patent has already been issued in other major markets including the U.S., EU, Japan and China
7:06am
, a recognized business development expert in the medical arena, and also a leading Israeli patent attorney and Partner & co-Founder of Cohn, de Vries, Stadler
6-K
EX-99.1
CANF
Can-Fite Biopharma Ltd
26 Oct 23
Can-Fite to Harness Artificial Intelligence to Develop Novel Anti-Cancer Drugs
7:11am
Pharmaceuticals, a leading expert in Artificial Intelligence and Machine Learning
PETACH TIKVA, Israel, October 26, 2023 -- Can-Fite BioPharma Ltd. (NYSE
6-K
EX-99.1
CANF
Can-Fite Biopharma Ltd
2 Nov 22
Report of Foreign Private Issuer
7:19am
Exhibit 99.1
Can-Fite: Positive New Data from it’s Phase III Psoriasis Study will be Presented
Today at an Industry Expert Summit in Boston
6-K
utyxpwif
2 Nov 22
Report of Foreign Private Issuer
7:19am
6-K
4p9j jadrpyot
2 May 22
Can-Fite’s CEO to Present Namodenoson’s Efficacy in Liver Cancer as Expert Speaker at the Adenosine Pathway Targeted Cancer Immunotherapy Summit
7:09am
6-K
EX-99.1
ti4 2f3z7z5ta
2 May 22
Can-Fite’s CEO to Present Namodenoson’s Efficacy in Liver Cancer as Expert Speaker at the Adenosine Pathway Targeted Cancer Immunotherapy Summit
7:09am
6-K
EX-99.1
279xhfmm1aao170h
28 Oct 20
Report of Foreign Private Issuer
4:31pm
6-K
EX-99.1
3uio0xgo
13 Feb 20
Notice of Special General Meeting of Shareholders
4:30pm
424B4
0arzh u7d0eryz
12 Feb 20
Prospectus supplement with pricing info
6:46am
F-1/A
ym4aywfh8igohlvi
3 Feb 20
Registration statement (foreign) (amended)
5:31pm
F-1
5t581d
24 Jan 20
Registration statement (foreign)
4:40pm
6-K
EX-99.1
s5goy
9 Jan 20
Notice of Special General Meeting of Shareholders
4:41pm
F-1/A
EX-10.1
h09 ulqfq
17 Oct 19
Registration statement (foreign) (amended)
5:29pm
20-F/A
qvq1osm4hk
2 Apr 19
Annual report (foreign) (amended)
6:52am